Results 71 to 80 of about 17,223 (183)
Case Report: New insights about clinical manifestations of patients with GCK genetic variants
GCK-MODY is a genetic condition characterized by alterations in the GCK gene, which can include several types of inactivating genetic variants - ranging from missense and nonsense variants, and splice site variants, to small and large deletions and ...
Ritiele Bastos de Souza +19 more
doaj +1 more source
Objective: This study aimed to evaluate the hypoglycemic effect of Cyclocarya paliurus on type 2 diabetic rats and its impact on glucagon-like peptide-1 (GLP-1) secretion, and to preliminarily explore its mechanism.
Yaqian ZOU +4 more
doaj +1 more source
An erratum on «A synonymous variant in GCK gene as a cause of gestational diabetes mellitus» by Natalya A. Zubkova, Petr M. Rubtsov, Liudmila I. Ibragimova, Nina A. Makretskaya, Evgeny V. Vasiliev, Vasily M. Petrov, Anatoly N. Tiulpakov (2019)
Natalia A. Zubkova +7 more
doaj +1 more source
Monogenic forms of diabetes mellitus, collectively classified as MODY (Maturity Onset Diabetes of the Young), represent rare, genetically determined variants of the disease with an autosomal dominant inheritance pattern, typically manifesting at a young ...
Svyatoslav M. Yurin +4 more
doaj +1 more source
Objective: β-cell dysfunction and loss are major pathological determinants of impaired islet function and hyperglycemia in diabetes. Given the inability of current therapies to restore β-cell viability or glucose-responsive insulin secretion, this study ...
Xiangyuan Meng +7 more
doaj +1 more source
Monogenic diabetes accounts for 5% of all incidence of hyperglycemia and Maturity Onset Diabetes of the Young (MODY) is the most common form. In GCK-MODY, one of the most common forms of MODY, hyperglycemia is caused by a mutation of a gene responsible ...
Barbara Katra +3 more
doaj +1 more source
Glucokinase and the potential of glucokinase activation in type 2 diabetes [PDF]
openaire +2 more sources
Nomenclature for mammalian glucokinase [PDF]
P B, Iynedjian, J, Girard
openaire +2 more sources
Resetting the glucose sensor: dorzagliatin and the evolution of glucokinase activation in diabetes therapy. [PDF]
Chang M, Shen P, Shen G.
europepmc +1 more source
Integrative In Silico Profiling of Major Phytochemicals From a Sclerocarya birrea-Nauclea latifolia-Piper longum Mixture: Docking, Molecular Dynamics, ADMET, and Ligand-Based Target Prediction on Shared Pathways in Type 2 Diabetes Mellitus and Alzheimer's Disease. [PDF]
Tientcheu JPD, İstifli ES.
europepmc +1 more source

